| ASSET | YEAR | % RETURN |
|---|---|---|
Gorilla Technology (GRRR) | 2023 | -95.4% |
FibroGen (FGEN) | 2023 | -94.5% |
Next Technology (NXTT) | 2023 | -94.32% |
Nutex Health (NUTX) | 2023 | -90.63% |
Katapult Holdings Equity Warrants Exp 09 June 2026 (KPLTW) | 2023 | -89.86% |
QuantaSing Group Limited American Depositary Shares (QSG) | 2023 | -88.61% |
Arqit Quantum (ARQQ) | 2023 | -86.87% |
AMC Entertainment (AMC) | 2023 | -85.22% |
SEALSQ (LAES) | 2023 | -84.94% |
KULR Technology (KULR) | 2023 | -83.9% |
Advent Technologies (ADNWW) | 2023 | -83.77% |
Emergent Biosolutions (EBS) | 2023 | -80.1% |
Vertical Aerospace (EVTL) | 2023 | -79.94% |
CuriosityStream (CURIW) | 2023 | -79.9% |
Novocure (NVCR) | 2023 | -79.86% |
Outset Medical (OM) | 2023 | -79.53% |
Palladyne AI (PDYN) | 2023 | -78.91% |
Arcutis Biotherapeutics (ARQT) | 2023 | -78.61% |
Canopy Growth (CGC) | 2023 | -78.44% |
Uxin (UXIN) | 2023 | -76.08% |
Intuitive Machines (LUNR) | 2023 | -75.78% |
ChargePoint (CHPT) | 2023 | -75.78% |
ProKidney (PROK) | 2023 | -75.68% |
Blue Ridge Bankshares (BRBS) | 2023 | -75.01% |
DeFi Development (DFDV) | 2023 | -74.25% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
